title: Patient safety considerations regarding dermal filler injections.
abstract: Today's population is seeking procedures that enhance or improve its appearance, that require little or no downtime, and that provide immediate results. Dermal filler injections are among the top five procedures performed for this purpose. Patient safety must remain the ultimate goal of any practitioner delivering such procedures. This column will examine pertinent safety considerations in relation to the delivery of dermal filler injections.
authors.affiliation: Aesthetic Advancements, Inc., Buford, GA 30519, USA. jjones@aestheticadvancements.com
authors.forename: Jill K
authors.initials: JK
authors.lastname: Jones
mesh_terms: D001672:Biocompatible Materials / Q000009:adverse effects / Q000627:therapeutic use*; D002482:Cellulose / Q000627:therapeutic use; D002985:Clinical Protocols; D003094:Collagen / Q000627:therapeutic use; D003357:Cosmetic Techniques / Q000009:adverse effects / Q000451:nursing* / Q000592:standards*; D004282:Documentation / Q000592:standards; D006040:Goals; D006801:Humans; D006820:Hyaluronic Acid / Q000627:therapeutic use; D007258:Informed Consent / Q000592:standards; D007271:Injections, Intradermal; D019344:Lactic Acid / Q000627:therapeutic use; D008353:Mannitol / Q000627:therapeutic use; D008487:Medical History Taking / Q000592:standards; D024802:Nurse's Role; D010353:Patient Education as Topic / Q000592:standards; D010808:Physical Examination / Q000592:standards; D011108:Polymers / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D017751:Safety Management / Q000458:organization & administration*; D015595:Skin Aging / Q000187:drug effects; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D001672:Biocompatible Materials; C498114:CosmoDerm; C482305:New-Fill; D011108:Polymers; C048470:glutaraldehyde-cross-linked collagen; D019344:Lactic Acid; D008353:Mannitol; D002482:Cellulose; D006820:Hyaluronic Acid; D003094:Collagen